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Toll-like receptors, 
MyD88, and sepsis
Toll-like receptors (TLRs), a group 
of membrane proteins that recognize 
many bacterial products, are now 
known to be central to the function 
of the innate immune system. Aft er 
binding by, say, lipopolysaccharide, 
TLR signals produce an infl ammatory 
response, oft en through activation 
of the NF-κB response. A critical 
intermediate in this signaling 
cascade is a protein called myeloid 
diff erentiation factor 88 (MyD88), 
an adaptor protein that binds to the 
TLR from the cytoplasmic side and 
mediates the activation of NF-κB. In 
a study reported in this issue, Dear et 
al. caused acute renal failure in mice 
by inducing sepsis resulting from 
puncture of the cecum. Th e animals 
all developed severe acute renal failure 
as well as some hepatic damage. Mice 
lacking TLR4 developed rates of sepsis 
and renal failure similar to those seen 
in the wild-type controls. But mice 
lacking MyD88 were protected from 
renal failure. However, these knockout 
mice had a similar degree of hepatic 
damage. See page 832. 




Tubular atrophy and interstitial 
fi brosis are common complications 
of diabetes and, like many other 
fi brotic complications, are not thought 
to be readily reversible. Fioretto et 
al. studied this problem in diabetic 
patients who had undergone pancreatic 
transplantation for type 1 diabetes and 
had been followed for 10 years. Using 
morphometric analysis, the researchers 
found that the volume of fraction 
occupied by the interstitium decreased 
aft er 10 years of normoglycemia. 
Similarly, the amount of interstitial 
collagen was reduced. Remarkably, the 
volume fraction of atrophic tubules 
was also reduced. Whether this was 
due to absorption of these tubules or 
‘rediff erentiation’ of these nephron 
segments remains to be determined. 
Unfortunately, arteriolar hyalinosis was 
not reduced. Although these results 
might be confounded by the fact that 
the dose of cyclosporin that patients 
were receiving decreased signifi cantly, 
by more than 50%, during the 10 years 
of follow-up, the fi nding of reversal of 
fi brosis (whatever its proximate cause) 
remains very interesting. See page 907. 
How many kinds 
of FSGS are there, 
and what are 
their individual 
prognoses?
Focal segmental glomerulosclerosis 
(FSGS) has many diverse pathologic 
presentations. In an important new 
study, Th omas et al. now provide an 
excellent clinical correlation between 
the pathologic description and the 
clinical outcome of patients with 
FSGS. Th ey studied forms of FSGS 
previously grouped into several 
types: cellular, collapsing, tip lesion, 
perihilar, and not readily classifi able. 
Collapsing FSGS was more likely to 
aff ect younger and black patients. 
Black race was uncommon in the tip 
variant. Patients who had collapsing 
and tip variants had higher proteinuria 
and lower serum albumin than 
patients with the other types of FSGS. 
Better renal function and less severe 
tubulointerstitial injury at histology 
were observed in patients with the 
tip variant. Th ese patients more oft en 
achieved complete remission and were 
more likely to receive steroids than the 
patients with other types of FSGS. Aft er 
a median follow-up of 1.8 years, 23% of 
all patients were on dialysis, and 28% 
had renal failure. Collapsing FSGS had 
the worst renal survival compared with 
other FSGS variants. See page 920. 
Stents are better 
than angioplasty in 
treating thrombosed 
grafts
In a study reported in this issue, Maya 
et al. queried a large vascular access 
database for the number of patients 
treated with thrombosed arteriovenous 
graft s wherein the thrombosis was 
at the venous anastomosis site. Th ey 
found 14 patients treated with stent 
placement, who were compared with 
a 34-patient matched group treated by 
angioplasty. Despite the fact that both 
procedures were immediately followed 
by equivalent rates of success, they 
resulted in diff erent rates of long-term 
survival. Patients who underwent stent 
placement lasted three times as long as 
those in the angioplasty group before 
their next interventions. Similarly, 
among those with permanent graft  
failure, patients with stents lasted 
longer before permanently abandoning 
their graft s, compared with those 
treated by angioplasty. Th e study 
clearly shows an improved survival 
rate of the graft  with stent placement, 
but it also highlights the need for 
a more powerful treatment for the 
serious and common problem of 
poor vascular access in hemodialysis. 
See page 934. 
